The Future of the U.S. Oncology Market: Preparing for Healthcare 2.0

This 15-page report presents cross-industry analysis on reimbursement and market access strategies designed to help you:

  • Overcome barriers to traditional premium pricing
  • Re-align stakeholder partnerships in the context of evidence-based care and clinical pathways
  • Leverage risk-sharing agreements as a mechanism of market access in the US
  • Achieve favorable reimbursement through ECV differentiation and value added services
  • Prepare for demands around companion diagnostics

Please subscribe to view the analysis report